ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Kronos Bio Inc

Kronos Bio Inc (KRON)

0.96
0.01
(1.05%)
Closed April 24 4:00PM
0.96
0.00
( 0.00% )
Pre Market: 4:00AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.96
Bid
0.95
Ask
1.04
Volume
-
0.00 Day's Range 0.00
0.731 52 Week Range 2.29
Market Cap
Previous Close
0.96
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
376,630
Shares Outstanding
58,316,520
Dividend Yield
-
PE Ratio
-0.50
Earnings Per Share (EPS)
-1.93
Revenue
6.29M
Net Profit
-112.67M

About Kronos Bio Inc

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was $0.96. Over the last year, Kronos Bio shares have traded in a share price range of $ 0.731 to $ 2.29.

Kronos Bio currently has 58,316,520 shares outstanding. The market capitalization of Kronos Bio is $55.98 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.50.

KRON Latest News

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results

Phase 1/2 study of KB-0742 is on track to clear 80mg four-days-on, three-days-off schedule in the third quarter of 2024; topline data from expansion cohort at this schedule expected in the first...

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

Company to assess KB-0742 at planned new dose schedule in ongoing phase 1/2 study; topline data from expansion cohort at new dose schedule expected in the first half of 2025 IND-enabling studies...

Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting

SAN MATEO, Calif. and CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-6.796116504851.031.070.911417710.95607419CS
4-0.3-23.80952380951.261.380.94536601.03638416CS
12-0.19-16.52173913041.151.40.93766301.09704969CS
260.089.090909090910.881.50530.7312891301.09594271CS
52-0.34-26.15384615381.32.290.7312831771.32321897CS
156-22.37-95.885126446623.3328.420.7312927646.56028556CS
260-27.33-96.606574761428.2939.6050.7312837879.47348477CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ILAGIntelligent Living Application Group Inc
$ 0.8402
(55.59%)
1.3M
AIREreAlpha Tech Corporation
$ 1.62
(39.66%)
760.62k
CDTXCidara Therapeutics Inc
$ 16.21
(31.90%)
10.17k
QNRXQuoin Pharmaceuticals Ltd
$ 0.8284
(31.06%)
2.29k
HKITHitek Global Inc
$ 1.63
(20.74%)
19.65k
ZAPPZapp Electric Vehicles Group Ltd
$ 2.67
(-31.71%)
465
FBLGraniteShares ETF Trust GraniteShares
$ 19.70
(-26.41%)
32.92k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3131
(-26.38%)
229.47k
BPTSBiophytis SA
$ 8.00
(-17.55%)
187
JAKKJAKKS Pacific Inc
$ 20.20
(-13.90%)
90
SBFMSunshine Biopharma Inc
$ 1.12
(20.43%)
1.46M
ILAGIntelligent Living Application Group Inc
$ 0.8402
(55.59%)
1.3M
SQQQProShares UltraPro Short QQQ
$ 12.16
(2.96%)
795.47k
AIREreAlpha Tech Corporation
$ 1.62
(39.66%)
760.62k
TQQQProShares UltraPro QQQ
$ 52.09
(-3.02%)
294.83k

Your Recent History

Delayed Upgrade Clock